IL-6 has been implicated as a key mediator of this systemic inflammatory response, and recent findings also highlight activated endothelial cells as a crucial contributor to IL-6 production, playing a substantial modulatory role in the severity of CRS [233]. Here, IL6 is linked to congenital rubella syndrome.